papaverine has been researched along with Critical Illness in 2 studies
Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
Critical Illness: A disease or state in which death is possible or imminent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ruzsa, Z | 1 |
| Róna, S | 1 |
| Tóth, GG | 1 |
| Sótonyi, P | 1 |
| Bertrand, OF | 1 |
| Nemes, B | 1 |
| Merkely, B | 1 |
| Hüttl, K | 1 |
| Heulitt, MJ | 1 |
| Farrington, EA | 1 |
| O'Shea, TM | 1 |
| Stoltzman, SM | 1 |
| Srubar, NB | 1 |
| Levin, DL | 1 |
1 trial available for papaverine and Critical Illness
| Article | Year |
|---|---|
Double-blind, randomized, controlled trial of papaverine-containing infusions to prevent failure of arterial catheters in pediatric patients.
Topics: Adolescent; Catheterization, Peripheral; Catheters, Indwelling; Child; Child, Preschool; Critical Il | 1993 |
1 other study available for papaverine and Critical Illness
| Article | Year |
|---|---|
Fractional flow reserve in below the knee arteries with critical limb ischemia and validation against gold-standard morphologic, functional measures and long term clinical outcomes.
Topics: Aged; Angiography; Angioplasty, Balloon; Blood Pressure; Blood Pressure Determination; Critical Illn | 2018 |